Skip to main content

Lunate Capital Ltd

SEC CIK
0002056786
Latest filing
Jul 23, 2026

Holdings in Q2 2026

Holdings as of Jun 30, 2026, filed Jul 23, 2026. Long positions only; changes compare share counts with Q1 2026.

Institution overview
Positions
10
+4 vs. Q1 2026
Portfolio value
$196.0M
+$75.6M (+62.8%) vs. Q1 2026
Filed
Jul 23, 2026
SEC
Holdings of Lunate Capital Ltd in Q2 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
SAILSailPoint, Inc.COM3,000,000$43.9M22.4%00.0%UnchangedHistory
BIRKBirkenstock Holding plcCOM SHS1,010,000$43.5M22.2%+1,010,000NewHistory
LINELineage, Inc.COM600,000$25.9M13.2%00.0%UnchangedHistory
BXSLBlackstone Secured Lending FundCOMMON STOCK1,000,818$23.7M12.1%+1,000,818NewHistory
GSBDGoldman Sachs BDC, Inc.SHS2,192,392$20.8M10.6%+2,192,392NewHistory
MSDLMorgan Stanley Direct Lending FundCOM SHS1,103,814$16.7M8.5%+1,103,814NewHistory
OBDCBlue Owl Capital CorpCOM1,200,244$13.0M6.7%+1,200,244NewHistory
NAVNNavan, Inc.CL A200,000$4.57M2.3%00.0%UnchangedHistory
NMRANeumora Therapeutics, Inc.COM2,124,143$3.61M1.8%00.0%UnchangedHistory
FIGFigma, Inc.Stock13,290$240.4K0.1%+13,290NewHistory

Sold out since Q1 2026 (2)

Positions held at the end of Q1 2026 that are gone from this filing.

Positions of Lunate Capital Ltd sold out since Q1 2026
SecurityClassShares in Q1 2026Value in Q1 2026% of portfolio in Q1 2026History
RVMDRevolution Medicines, Inc.COM549,050$53.4M44.4%History
RVMDWRevolution Medicines, Inc.*W EXP 12/17/202450,000$805.5K0.7%History